| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |